Key result
Oseltamivir resolves primary influenza B pneumonia in a lupus nephritis patient following IV cyclophosphamide.
Case Report (n=1)
Highlights the importance of considering influenza pneumonia in the differential diagnosis of diffuse pulmonary infiltration in immunosuppressed patients with lupus.
Answers are grounded in this paper and cite their sources.
Supports vigilance for influenza pneumonia in immunosuppressed lupus patients with infiltrates; leaves open broader oseltamivir efficacy.
Infectious diseases, particularly pneumonia, remain a major cause of morbidity and mortality in patients with systemic lupus erythematous (SLE), accounting for 30∼50% of all death.Because infection appears in various forms in lupus patients, early detection and appropriate treatment is very important.In the case of diffuse infiltration in the whole lung field, we should make a differential diagnosis with drug-induced pneumonitis, interstitial lung disease and pneumonia caused by atypical microorganism infection.In particular, in case of atypical microorganism pneumonia, we usually suspect cytomegalovirus, pneumocystis jiroveci and ebstein-barr virus, but influenza pneumonia is relatively neglected.Here, we report on the case of a 26-year-old female patient with lupus nephritis who presented with dyspnea and diffuse pulmonary infiltration immediately after intravenous cyclophosphamide.She was diagnosed with primary influenza B pneumonia and successfully treated with oseltamivir.
No takes yet. Share an insight, caveat, or question.
Park et al. (2011) conducted a case report in Lupus nephritis and primary influenza B pneumonia (n=1). Oseltamivir was evaluated on Clinical recovery. A female patient with lupus nephritis who developed primary influenza B pneumonia after intravenous cyclophosphamide was successfully treated with oseltamivir.
Synapse has enriched 10 related papers. Consider them for comparative context: